-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/malnutrition-hospitalized-adults-protocol.pdf
October 19, 2020 - While sarcopenic obesity has been described in
hospitalized patients, most screening tools do not capture … daily living, quality of life, readmission, hospital acquired
conditions, and discharge disposition as described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
October 12, 2016 - We
mentioned in our list of study limitations
that many interventions described as n-3
FA (especially … In my opinion
details and characteristics are more than sufficient,
and very clearly described, once … The Gustafson study was
described narratively in the section on
cognitive outcomes, although one domain … TEP Reviewer
#4
Results In general results present enough detail and studies
are clearly described … TEP Reviewer
#4
Discussion/Conclusion Limitations are well described and implications of the
major
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/behavioral-health-screening-disposition-comments.pdf
April 09, 2025 - Concerns
about this are further described below. … TEP Reviewer
1
Discussion As described above, there may be important lessons that are missed
because … We described
our approach to doing this in the paragraph
that starts on page 33, line 34. … the ERIC/EPOC taxonomies
that were utilized to classify the
implementation strategies that were
described … Clinical practice implications and limitations are well described.
Thank you for your comment.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
October 01, 2014 - We found three published studies that described use of bone scans to evaluate treatment of
metastatic … We identified four published studies9,15,16,20 that described use of MRI to evaluate treatment
of metastatic … use of FDG,10,11,14-17,20,21,23,24 four described FLT,12,13,18,22 one
described F-FMISO,11 and two … described FES19,20 (two studies evaluated more than one kind of
tracer). … PET scans conducted 1990-1994
using tracer MET, now obsolete (1)
Described diagnostic breast imaging
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
August 27, 2012 - Perhaps in sections within the ES and the Full
Report where disparities indicators are described. … We have removed the names of the RCTs;
they are described in the Full Report. … TEP #2 Methods Conditions: same problems as described for Executive
Summary. … TEP #3 Discussion/ Conclusion The limitations are described adequately. … We have ordered the interventions as
described above.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
May 01, 2013 - However, the Two-
Question screen is not mentioned/described
immediately before or after Table A. … Peer Reviewer 1 Results Yes, the studies are described with clarity and
enough detail. … TEP Member 2 Results The studies were described well for the intevention-
--impact of screening but less … They were well
described for the "setting" quesiton. … The
methodology is clearly described and of the highest
quality.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methodological-recommendations-framework-communications_research.pdf
September 01, 2013 - It comprises a series of four steps
described in the following sections. … Further, as described next, it is
preferable to avoid recommendations that mix together testable and … explicit description.
13
the presence of publication bias (and assuming the generative story described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - 4 months with no change in pain intensity or
function.13
• Two studies in the systematic reviews described … We did find a third systematic review that described mobile
applications for opioid use disorder (presence … development of the applications
and incorporation of features that were not evidence-based or fully described … local experts with expertise in pain management and opioid tapering, in
order to assess the criteria described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - 4 months with no change in pain intensity or
function.13
• Two studies in the systematic reviews described … We did find a third systematic review that described mobile
applications for opioid use disorder (presence … development of the applications
and incorporation of features that were not evidence-based or fully described … local experts with expertise in pain management and opioid tapering, in
order to assess the criteria described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-disposition-comments.pdf
March 31, 2025 - Each study measured and described breastfeeding
differently and used different comparisons for
analyses … The focus of this report and the population of interest
(as described in Table 1) is term infants. … Each health
outcome is further described in terms of each study
characteristic both from existing systematic … You have already
described the limitations previously. … While a number of
characteristics were described for each study,
additional details (such as measurement
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/outcome-research-white-paper.pdf
June 01, 2022 - The rationale for the
selection of these measures and the measure definitions are described in a separate … The work described in Chapter 2 focused on ensuring that the
data elements necessary to calculate the … The registries work with the same technical vendor, and the data quality steps described below
are the … These efforts and the
resulting tools are described further below. … Both products are described further below.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hemorrhage-postpartum_executive.pdf
April 01, 2015 - In
addition, PPH may be described as third
or fourth stage depending on whether
it occurs before or … context of the population,
intervention, comparator, outcomes, timing, and setting
(PICOTS) parameters described … for Healthcare Research and Quality standard
of “good,” “fair,” and “poor” quality designations, as
described … the
observational data are biased and a single very large trial suggests
that at least one clearly described … Management was not
well described in many studies, especially for women
who transferred from other
-
effectivehealthcare.ahrq.gov/sites/default/files/worker-health_disposition-comments.pdf
May 31, 2016 - We did include the type of studies
described here as parallel- e.g.,
worksites that had existing OSH … Peer Reviewer
#3
Discussion The major finding as clearly stated with limitations adequately
described … Limitations well described. I am
not aware of missing studies. … Peer Reviewer
#5
Discussion The limitations are well described. … Similar (and sometimes better)
results have been described for health promotion programs
that were
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/trauma-child-interventions_research-protocol.pdf
March 26, 2012 - Specific clinical interventions are described below. … Analytic Framework
Figure 1 depicts the KQs within the context of the PICOS described in the previous … The steps that we will take
to accomplish the literature review are described below. … To assess
the risk of bias of studies, we will use criteria described in the AHRQ Methods Guide
for … The grades of
evidence that can be assigned are described in Table 4.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
June 01, 2013 - not in use in the United States.
7
Study Selection
Using the inclusion and exclusion criteria described … Risk-of-Bias Assessment of Individual Studies
The included studies were assessed using the approach
described … evaluate methodological quality, we
applied criteria for each study type derived from core
elements described … Evidence
The strength of evidence for each Key Question and
outcome was assessed using the approach described … studies
in the meta-analyses, and reasons for excluding any
studies that were not incorporated, are described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/quality-gap-palliative-hospice_disposition-comments.pdf
October 01, 2012 - the focus on quality improvement interventions is
logical, the rationale for this is not adequately described … We have described our rationale for using
the 2000 cutoff in the introduction and
methods sections … As described, many of the
pilot studies included in this report are health services
interventions in … Are the characteristics of the studies clearly
described? … The
characteristics of the study are clear and well described.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicide-prevention_disposition-comments.pdf
October 04, 2016 - More detail on how to
overcome the barriers to data linkage that are described
would be helpful. … The search strategies are explicitly
described and appear to e logical. … Reviewer
#3
Discussion/
conclusion
The current obstacles to more effective data linkage are
clearly described … What some of the potential benefits
could be of better linkage could be more thoroughly
described.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
June 06, 2011 - questions (KQs) within the context of the PICO (population,
interventions, comparators, and outcomes) described … We will evaluate the quality of individual studies using the approach
described in the Methods Guide … methodological quality, we will
apply criteria for each study type that are derived from the core elements described … Question
The strength of evidence for each key question will be assessed by using the
approach described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-i.xlsx
January 01, 2019 - classification Yes Overall survival Hazard ratio Definitely no No protocol available and subgroup analyses described … Alliance] Age Yes Overall survival Hazard ratio Definitely no No protocol available and subgroup analyses described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-nonpharmacologic-treatment_research-protocol.pdf
October 04, 2016 - considered for inclusion if they
describe adverse events associated with thermoplasty that have not been described … asthma-control composite
measures, asthma-exacerbation measures, and asthma-related quality of life, as described